Confrontation looms for big pharmaceutical companies, generic drug makers

The New York Times: For Big Drug Companies, A Headache Looms
It would seem a business executive's dream: legally pay a competitor to keep its product off the market for years. Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it. Until this month (Wyatt, 7/26).